Cita APA (7a ed.)

Suzuki, S., Toyoma, S., Kawasaki, Y., Koizumi, K., Iikawa, N., Shiina, K., . . . Yamada, T. (2021). Clinical Outcomes of Cetuximab and Paclitaxel after Progression on Immune Checkpoint Inhibitors in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma. MDPI AG.

Cita Chicago Style (17a ed.)

Suzuki, Shinsuke, et al. Clinical Outcomes of Cetuximab and Paclitaxel After Progression on Immune Checkpoint Inhibitors in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma. MDPI AG, 2021.

Cita MLA (8a ed.)

Suzuki, Shinsuke, et al. Clinical Outcomes of Cetuximab and Paclitaxel After Progression on Immune Checkpoint Inhibitors in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma. MDPI AG, 2021.